A Randomized, Double-blind, Placebo-controlled, Single and Multiple Dose Escalation Phase I Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of IMC-003 for Injection in Healthy Postmenopausal Women

NCT07118085 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

56

Enrollment

OTHER

Sponsor class

Conditions

Healthy Postmenopausal Women

Interventions

DRUG: experimental Arm IMC-003
DRUG: The placebo Arm: The placebo of IMC-003

Sponsor

ImmuneOnco Biopharmaceuticals (Shanghai) Inc.